Showing 4781-4790 of 8723 results for "".
- Bellus Medical Now Part of Crown Laboratorieshttps://practicaldermatology.com/news/bellus-medical-now-part-of-crown-laboratories/2457590/Crown Laboratories, Inc. and Hildred Capital Partners, LLC have acquired Bellus Medical. Bellus’s non-invasive offerings include the SkinPen, a medical grade microneedling device used exclusively by healthcare professionals to improve the appearance of facial acne scars. It is the f
- RealSelf Survey: More than 1 in 3 US Adults are Considering Nips/Tuckshttps://practicaldermatology.com/news/realself-survey-more-than-1-in-3-us-adults-are-considering-nipstucks/2457591/One in three adults (37 percent) in the US are considering at least one cosmetic treatment in the next 12 months, with significantly more considering nonsurgical procedures (34 percent) than surgical ones (24 percent), according to the
- Scar-Less Healing May be on the Horizonhttps://practicaldermatology.com/news/scar-less-healing-may-be-on-the-horizon/2457595/Stromal cell-derived-factor-1 (SDF1), a compound secreted in the bloodstream, may be the key factor that causes wounds in older people to heal with less scarring than in younger people, according to researchers from the Perelman School of Medicine at the Univer
- Celebrity Manicurist Joins with Galderma for "Face Your Hands" Campaignhttps://practicaldermatology.com/news/celebrity-manicurist-deborah-lippmann-joins-with-galderma-for-face-your-hands-campaign/2457596/Galderma Laboratories, L.P.,’s Restylane® Lyft is partnering with celebrity manicurist Deborah Lippmann for the "Face Your Hands" campaign, which aims to educate women on the steps they can take to achieve more youthful hands. A
- Almirall Finalizes Acquisition of Allergan US Medical Dermatology Portfoliohttps://practicaldermatology.com/news/almirall-finalizes-acquisition-of-allergan-us-medical-dermatology-portfolio/2457600/Almirall, S.A. finalized its acquisition of products from Allergan's Medical Dermatology unit in the US: Aczone (dapsone), Tazorac (tazarotene), Azelex (azelaic acid), and Cordran Tape (flurandrenolide). In addition, sarecycline, a New Chemical Entity (NCE) currently under FDA review for appr
- FDA Clears Sebacia Microparticles for Laser-Based Acne Treatmenthttps://practicaldermatology.com/news/fda-clears-sebacia-microparticles-for-laser-based-acne-treatment/2457603/Sebacia Microparticles are now FDA-cleared for use in the treatment of acne. The clearance comes on the heels of a pivotal study demonstrating the clinical safety and efficacy of the micoparticles. Sebacia, Inc. had submitted its 510(k) submission to the FDA in June 2018. Sebacia Mic
- ASDS 2018 Survey: Patients Spend About $100 Per Month on Skin Care Productshttps://practicaldermatology.com/news/asds-2018-survey-patients-spend-about-100-per-month-on-skin-care-products/2457608/Almost 70 percent of consumers are considering a cosmetic treatment, and more than half would prefer to pay more up front to lower their annual skin care costs, according to the 2018 American Society for Dermatologic Surgery (ASDS) Consumer Survey on Cosmetic Der
- First-Ever Molecular Study Shows African American Skin Reacts Differently to ADhttps://practicaldermatology.com/news/first-ever-molecular-study-shows-african-american-skin-reacts-differently-to-ad/2457612/African Americans are known to have greater treatment challenges with atopic dermatitis than European Americans and require higher doses of some medications to get relief, and now a new study suggests that differences in the molecular profile of their skin may be the reason. About 19 perc
- Inaugural World Eczema Day: GlobalSkin Launches International Movement for Eczema Sufferershttps://practicaldermatology.com/news/inaugural-world-eczema-day-globalskin-launches-international-movement-for-eczema-sufferers/2457611/To mark the first-ever Atopic Eczema Day, the International Alliance of Dermatology Patient Organizations (IADPO – also known as GlobalSkin) has launched AltogetherEczema, a new movement to elevate the urgent and unmet needs of the global eczema and atopic dermatitis community.
- Allergan Launches Spotlyte: Digital Hub Will Educate Consumers About Medical Aesthetic Treatmentshttps://practicaldermatology.com/news/allergan-launches-spotlyte/2457615/Allergan has launched Spotlyte, described as an innovative digital hub of curated content that helps consumers discover how medical aesthetic treatments may fit into their routines.